Abdelaziz A Awad, Abdelrahman M Elettreby, Ahmed A Abo Elnaga, Mohamed A Alsaied, Dalia Kamal Ewis, Yousef R Alnomani, Fatma Mohammed, Mazen M Sinjab, Abdulla Turki Alsubaey, Zaki Shannak, Hashem Abu Serhan
{"title":"穿透性角膜移植和深前板层角膜移植治疗角膜黄斑营养不良的疗效和安全性:一项系统综述和荟萃分析。","authors":"Abdelaziz A Awad, Abdelrahman M Elettreby, Ahmed A Abo Elnaga, Mohamed A Alsaied, Dalia Kamal Ewis, Yousef R Alnomani, Fatma Mohammed, Mazen M Sinjab, Abdulla Turki Alsubaey, Zaki Shannak, Hashem Abu Serhan","doi":"10.1155/joph/8867750","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To compare efficacy and safety for deep anterior lamellar keratoplasty (DALK) versus penetrating keratoplasty (PK) for macular corneal dystrophy. <b>Methods:</b> Following PRISMA guidelines, we searched four electronic databases (PubMed, Scopus, Cochrane Library, and Web of Science) to identify eligible studies reported up to January 2024. Using STATA 17, we reported outcomes as log risk ratios (log RRs) or mean difference (SMD) and confidence intervals (CIs). A <i>p</i> value ≤ 0.05 is considered statistically significant. <b>Results:</b> DALK was superior to PK in terms of BCVA (Hedge's g: -0.32 with 95% CI [-0.64, -0.01], <i>p</i>=0.05), PK was associated with a higher risk of graft rejection in comparison with DALK (log RR: 1.21 with 95% CI [0.25, 2.18], <i>p</i>=0.01), and there was no difference between PK and DALK in terms of risk of glaucoma, cataract (log RR: -0.02 with 95% CI [-1.00, 0.95], <i>p</i>=0.96), and (log RR: 0.09 with 95% CI [-0.53, 0.71], <i>p</i>=0.78). The pooled data were homogeneous (<i>I</i> <sup>2</sup> = 0%; <i>p</i>=0.84), respectively. <b>Conclusion:</b> This study suggests that PK, compared to DALK, is associated with worse visual outcomes, with a lower risk of recurrence and a higher risk of graft rejection in macular corneal dystrophy patients.</p>","PeriodicalId":16674,"journal":{"name":"Journal of Ophthalmology","volume":"2025 ","pages":"8867750"},"PeriodicalIF":1.9000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349984/pdf/","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Penetrating Keratoplasty and Deep Anterior Lamellar Keratoplasty in Corneal Macular Dystrophy: A Systematic Review and Meta-Analysis.\",\"authors\":\"Abdelaziz A Awad, Abdelrahman M Elettreby, Ahmed A Abo Elnaga, Mohamed A Alsaied, Dalia Kamal Ewis, Yousef R Alnomani, Fatma Mohammed, Mazen M Sinjab, Abdulla Turki Alsubaey, Zaki Shannak, Hashem Abu Serhan\",\"doi\":\"10.1155/joph/8867750\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose:</b> To compare efficacy and safety for deep anterior lamellar keratoplasty (DALK) versus penetrating keratoplasty (PK) for macular corneal dystrophy. <b>Methods:</b> Following PRISMA guidelines, we searched four electronic databases (PubMed, Scopus, Cochrane Library, and Web of Science) to identify eligible studies reported up to January 2024. Using STATA 17, we reported outcomes as log risk ratios (log RRs) or mean difference (SMD) and confidence intervals (CIs). A <i>p</i> value ≤ 0.05 is considered statistically significant. <b>Results:</b> DALK was superior to PK in terms of BCVA (Hedge's g: -0.32 with 95% CI [-0.64, -0.01], <i>p</i>=0.05), PK was associated with a higher risk of graft rejection in comparison with DALK (log RR: 1.21 with 95% CI [0.25, 2.18], <i>p</i>=0.01), and there was no difference between PK and DALK in terms of risk of glaucoma, cataract (log RR: -0.02 with 95% CI [-1.00, 0.95], <i>p</i>=0.96), and (log RR: 0.09 with 95% CI [-0.53, 0.71], <i>p</i>=0.78). The pooled data were homogeneous (<i>I</i> <sup>2</sup> = 0%; <i>p</i>=0.84), respectively. <b>Conclusion:</b> This study suggests that PK, compared to DALK, is associated with worse visual outcomes, with a lower risk of recurrence and a higher risk of graft rejection in macular corneal dystrophy patients.</p>\",\"PeriodicalId\":16674,\"journal\":{\"name\":\"Journal of Ophthalmology\",\"volume\":\"2025 \",\"pages\":\"8867750\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349984/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/joph/8867750\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/joph/8867750","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:比较深前板层角膜移植术(DALK)与穿透性角膜移植术(PK)治疗黄斑角膜营养不良的疗效和安全性。方法:根据PRISMA指南,我们检索了四个电子数据库(PubMed, Scopus, Cochrane Library和Web of Science),以确定截至2024年1月报道的符合条件的研究。使用STATA 17,我们以对数风险比(log rr)或平均差(SMD)和置信区间(CIs)报告结果。p值≤0.05认为有统计学意义。结果:在BCVA方面,DALK优于PK (Hedge’s g: -0.32, 95% CI [-0.64, -0.01], p=0.05),与DALK相比,PK与更高的移植排斥风险相关(对数RR: 1.21, 95% CI [0.25, 2.18], p=0.01),在青光眼、白内障的风险方面,PK与DALK之间无差异(对数RR: -0.02, 95% CI [-1.00, 0.95], p=0.96),(对数RR: 0.09, 95% CI [-0.53, 0.71], p=0.78)。合并的数据是均匀的(i2 = 0%;分别p = 0.84)。结论:本研究表明,与DALK相比,PK与黄斑角膜营养不良患者的视力结果较差,复发风险较低,移植物排斥反应风险较高。
Efficacy and Safety of Penetrating Keratoplasty and Deep Anterior Lamellar Keratoplasty in Corneal Macular Dystrophy: A Systematic Review and Meta-Analysis.
Purpose: To compare efficacy and safety for deep anterior lamellar keratoplasty (DALK) versus penetrating keratoplasty (PK) for macular corneal dystrophy. Methods: Following PRISMA guidelines, we searched four electronic databases (PubMed, Scopus, Cochrane Library, and Web of Science) to identify eligible studies reported up to January 2024. Using STATA 17, we reported outcomes as log risk ratios (log RRs) or mean difference (SMD) and confidence intervals (CIs). A p value ≤ 0.05 is considered statistically significant. Results: DALK was superior to PK in terms of BCVA (Hedge's g: -0.32 with 95% CI [-0.64, -0.01], p=0.05), PK was associated with a higher risk of graft rejection in comparison with DALK (log RR: 1.21 with 95% CI [0.25, 2.18], p=0.01), and there was no difference between PK and DALK in terms of risk of glaucoma, cataract (log RR: -0.02 with 95% CI [-1.00, 0.95], p=0.96), and (log RR: 0.09 with 95% CI [-0.53, 0.71], p=0.78). The pooled data were homogeneous (I2 = 0%; p=0.84), respectively. Conclusion: This study suggests that PK, compared to DALK, is associated with worse visual outcomes, with a lower risk of recurrence and a higher risk of graft rejection in macular corneal dystrophy patients.
期刊介绍:
Journal of Ophthalmology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the anatomy, physiology and diseases of the eye. Submissions should focus on new diagnostic and surgical techniques, instrument and therapy updates, as well as clinical trials and research findings.